LPL Financial LLC - PROVECTUS BIOPHARMACEUTICALS ownership

PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 41 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LPL Financial LLC ownership history of PROVECTUS BIOPHARMACEUTICALS
ValueSharesWeighting
Q3 2016$5,000
-76.2%
59,2000.0%0.00%
Q2 2016$21,000
-51.2%
59,200
-50.0%
0.00%
Q1 2016$43,000
-8.5%
118,4000.0%0.00%
Q4 2015$47,000
+42.4%
118,400
+100.0%
0.00%
Q3 2015$33,000
+3.1%
59,200
-3.3%
0.00%
Q2 2015$32,000
-34.7%
61,2000.0%0.00%
Q1 2015$49,000
-3.9%
61,200
-3.2%
0.00%
Q4 2014$51,000
+8.5%
63,200
+33.9%
0.00%
Q3 2014$47,000
+20.5%
47,200
+4.4%
0.00%
Q2 2014$39,00045,2000.00%
Other shareholders
PROVECTUS BIOPHARMACEUTICALS shareholders Q3 2016
NameSharesValueWeighting ↓
HOME FEDERAL BANK OF TENNESSEE 100,000$8,5000.00%
LEE DANNER & BASS INC 50,000$40.00%
LBMC INVESTMENT ADVISORS, LLC 22,000$1,7160.00%
Atlas Wealth LLC 26,620$2,2490.00%
ACADEMY CAPITAL MANAGEMENT INC/TX 20,000$1,6900.00%
HUNTINGTON NATIONAL BANK 1$00.00%
View complete list of PROVECTUS BIOPHARMACEUTICALS shareholders